Omada Health (NASDAQ:OMDA) CEO Sean Duffy Sells 2,800 Shares

Omada Health, Inc. (NASDAQ:OMDA) CEO Sean Duffy sold 2,800 shares of the business’s stock in a transaction that occurred on Wednesday, June 24th. The shares were sold at an average price of $19.01, for a total transaction of $53,228.00. Following the transaction, the chief executive officer directly owned 409,061 shares of the company’s stock, valued at approximately $7,776,249.61. This represents a 0.68% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website.

Omada Health Price Performance

NASDAQ:OMDA traded up $1.99 during trading hours on Friday, hitting $20.89. The stock had a trading volume of 3,310,497 shares, compared to its average volume of 946,807. The company has a 50 day simple moving average of $16.51 and a two-hundred day simple moving average of $14.85. The firm has a market capitalization of $1.24 billion and a price-to-earnings ratio of -77.37. Omada Health, Inc. has a one year low of $10.28 and a one year high of $26.92.

Omada Health (NASDAQ:OMDA) last issued its quarterly earnings data on Thursday, May 7th. The company reported ($0.05) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.08) by $0.03. Omada Health had a negative return on equity of 1.82% and a negative net margin of 2.22%.The company had revenue of $78.05 million for the quarter. Equities research analysts anticipate that Omada Health, Inc. will post -0.01 earnings per share for the current year.

Hedge Funds Weigh In On Omada Health

A number of large investors have recently modified their holdings of OMDA. Geode Capital Management LLC bought a new stake in Omada Health in the 2nd quarter worth approximately $637,000. Walleye Capital LLC bought a new position in Omada Health during the second quarter valued at approximately $458,000. Ilex Capital Partners UK LLP purchased a new position in shares of Omada Health during the second quarter worth approximately $201,000. Soros Fund Management LLC purchased a new position in shares of Omada Health during the second quarter worth approximately $640,000. Finally, Raymond James Financial Inc. bought a new stake in shares of Omada Health in the 2nd quarter worth approximately $32,000.

Analyst Ratings Changes

Several research firms recently weighed in on OMDA. BMO Capital Markets decreased their price objective on shares of Omada Health from $27.00 to $18.00 and set an “outperform” rating on the stock in a research report on Friday, March 6th. Canaccord Genuity Group set a $24.00 price target on shares of Omada Health in a research note on Friday, May 8th. Citizens Jmp increased their price target on shares of Omada Health from $18.00 to $21.00 and gave the stock a “market outperform” rating in a report on Friday, May 8th. Citigroup restated an “outperform” rating on shares of Omada Health in a research report on Friday, May 8th. Finally, The Goldman Sachs Group reaffirmed a “buy” rating on shares of Omada Health in a report on Friday, May 8th. Ten analysts have rated the stock with a Buy rating, two have given a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, Omada Health has a consensus rating of “Moderate Buy” and an average price target of $22.91.

Omada Health Company Profile

Omada Health is a digital health company that specializes in the prevention and management of chronic conditions through personalized, technology-driven programs. The company’s platform combines data analytics, behavioral science and human coaching to support individuals at risk for or living with conditions such as prediabetes, type 2 diabetes, hypertension and musculoskeletal disorders. Participants access the program via a mobile app or web portal, where they receive tailored curriculum, feedback on health metrics and ongoing virtual coaching.

In addition to its core disease-management offerings, Omada Health has expanded its services to include mental health support and digital therapeutics for weight management.